chr7-30599995-G-A

Position:

• chr7-30599995-G-A

Variant summary

Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PM2 PM5 PP3_Moderate PP5_Moderate

The NM_002047.4(GARS1):​c.373G>A​(p.Glu125Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E125G) has been classified as Pathogenic.

• Frequency: Genomes: not found (cov: 32)
• Consequence: GARS1 NM_002047.4 missense
• Clinical Significance: Pathogenic criteria provided, single submitter P:2
• Conservation: PhyloP100: 9.96

Genes affected

GARS1 (HGNC:4162): (glycyl-tRNA synthetase 1) This gene encodes glycyl-tRNA synthetase, one of the aminoacyl-tRNA synthetases that charge tRNAs with their cognate amino acids. The encoded enzyme is an (alpha)2 dimer which belongs to the class II family of tRNA synthetases. It has been shown to be a target of autoantibodies in the human autoimmune diseases, polymyositis or dermatomyositis. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2015]

ACMG classification

Verdict is Likely_pathogenic. Variant got 8 ACMG points.

• PM2: Very rare variant in population databases, with high coverage
• PM5: Other missense variant is known to change same aminoacid residue: Variant chr7-30599996-A-G is described in Lovd as [Pathogenic].
• PP3: MetaRNN computational evidence supports a deleterious effect, 0.844
• PP5: Variant 7-30599995-G-A is Pathogenic according to our data. Variant chr7-30599995-G-A is described in ClinVar as [Pathogenic]. Clinvar id is 208650.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr7-30599995-G-A is described in Lovd as [Pathogenic].

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	MANE	Protein	UniProt
GARS1	NM_002047.4	c.373G>A	p.Glu125Lys	missense_variant	3/17	ENST00000389266.8	NP_002038.2
GARS1	NM_001316772.1	c.211G>A	p.Glu71Lys	missense_variant	3/17		NP_001303701.1

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	TSL	MANE	Protein	Appris	UniProt
GARS1	ENST00000389266.8	c.373G>A	p.Glu125Lys	missense_variant	3/17	1	NM_002047.4	ENSP00000373918.3
GARS1	ENST00000675651.1	c.373G>A	p.Glu125Lys	missense_variant	3/17			ENSP00000502513.1
GARS1	ENST00000675810.1	c.271G>A	p.Glu91Lys	missense_variant	2/16			ENSP00000502743.1
GARS1	ENST00000675693.1	c.205G>A	p.Glu69Lys	missense_variant	4/18			ENSP00000502174.1
GARS1	ENST00000675051.1	c.172G>A	p.Glu58Lys	missense_variant	3/17			ENSP00000502296.1
GARS1	ENST00000674815.1	c.4G>A	p.Glu2Lys	missense_variant	3/17			ENSP00000502799.1
GARS1	ENST00000674851.1	c.4G>A	p.Glu2Lys	missense_variant	4/18			ENSP00000502451.1
GARS1	ENST00000444666.6	n.373G>A		non_coding_transcript_exon_variant	3/18	3		ENSP00000415447.2
GARS1	ENST00000674616.1	n.*87G>A		non_coding_transcript_exon_variant	4/18			ENSP00000502408.1
GARS1	ENST00000674643.1	n.373G>A		non_coding_transcript_exon_variant	3/17			ENSP00000501636.1
GARS1	ENST00000674737.1	n.373G>A		non_coding_transcript_exon_variant	3/18			ENSP00000502464.1
GARS1	ENST00000674807.1	n.373G>A		non_coding_transcript_exon_variant	3/16			ENSP00000502814.1
GARS1	ENST00000675529.1	n.*243G>A		non_coding_transcript_exon_variant	4/18			ENSP00000501655.1
GARS1	ENST00000675859.1	n.373G>A		non_coding_transcript_exon_variant	3/15			ENSP00000502033.1
GARS1	ENST00000676088.1	n.*243G>A		non_coding_transcript_exon_variant	4/19			ENSP00000501884.1
GARS1	ENST00000676140.1	n.373G>A		non_coding_transcript_exon_variant	3/17			ENSP00000502571.1
GARS1	ENST00000676164.1	n.373G>A		non_coding_transcript_exon_variant	3/17			ENSP00000501986.1
GARS1	ENST00000676210.1	n.373G>A		non_coding_transcript_exon_variant	3/18			ENSP00000502373.1
GARS1	ENST00000676259.1	n.373G>A		non_coding_transcript_exon_variant	3/17			ENSP00000501980.1
GARS1	ENST00000676403.1	n.373G>A		non_coding_transcript_exon_variant	3/16			ENSP00000502681.1
GARS1	ENST00000674616.1	n.*87G>A		3_prime_UTR_variant	4/18			ENSP00000502408.1
GARS1	ENST00000675529.1	n.*243G>A		3_prime_UTR_variant	4/18			ENSP00000501655.1
GARS1	ENST00000676088.1	n.*243G>A		3_prime_UTR_variant	4/19			ENSP00000501884.1

Frequencies

GnomAD3 genomes Cov.: 32

GnomAD4 exome Cov.: 31

GnomAD4 genome Cov.: 32

ClinVar

Significance: Pathogenic

Submissions summary: Pathogenic:2

Revision: criteria provided, single submitter

Submissions by phenotype

Inborn genetic diseases Pathogenic:1

Pathogenic, criteria provided, single submitter

clinical testing

Ambry Genetics

Nov 22, 2013

- -

Spinal muscular atrophy, infantile, James type Pathogenic:1

Pathogenic, no assertion criteria provided

literature only

OMIM

Oct 15, 2020

- -

Computational scores

Source: dbNSFP v4.3

Name	Calibrated prediction	Score	Prediction
AlphaMissense	Pathogenic	0.99
BayesDel_addAF	Pathogenic	0.26	D
BayesDel_noAF	Pathogenic	0.14
CADD	Pathogenic	30
DANN	Pathogenic	1.0
DEOGEN2	Uncertain	0.71	D
Eigen	Pathogenic	0.83
Eigen_PC	Pathogenic	0.84
FATHMM_MKL	Pathogenic	0.99	D
LIST_S2	Uncertain	0.97	D
M_CAP	Uncertain	0.18	D
MetaRNN	Pathogenic	0.84	D
MetaSVM	Uncertain	0.15	D
PrimateAI	Pathogenic	0.87	D
PROVEAN	Uncertain	-3.9	D
REVEL	Pathogenic	0.71
Sift	Benign	0.050	D
Sift4G	Uncertain	0.040	D
Polyphen		0.96	D
Vest4		0.95
MutPred		0.47		Gain of MoRF binding (P = 0.0084);
MVP		0.84
MPC		1.2
ClinPred		0.99	D
GERP RS		5.6
Varity_R		0.79
gMVP		0.89

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.0		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Other links and lift over

dbSNP: rs797044855; hg19: chr7-30639611;